Information updates

Abbott infant formula recall

Abbott Australasia Pty Ltd and Abbott US are conducting a precautionary recall of some EleCare, Similac and Alimentum infant formula products, due to the possible microbial contamination (Cronobacter and Salmonella), which may cause illness if consumed. These products are manufactured in Abbott’s Sturgis plant in the United States and are available through prescription at pharmacies, hospitals and via direct mail order. ​

Only products with specific codes and expiry dates are being recalled, which can be identified by the 7 to 9 digit code and expiration date on the bottom of the package. Products are included in the recall if they have all of the following three items:

• First two digits of the code are 22 through 37 and
• Code on the container contains K8, SH, or Z2, and
• Expiration date is 1 April 2022 (APR 2022) or later.​

If you are affected by this recall, you should change to a suitable alternative product as soon as possible. Alternative formula and milk products are listed on the ASCIA website:

www.allergy.org.au/hp/papers/guide-for-milk-substitutes-cows-milk-allergy

For further information contact Abbott Australasia Pty Ltd www.abbottnutrition.com.au  Customer Service Number 1800 225 311.

Information about the product recall is available on the FSANZ website:

https://www.foodstandards.gov.au/industry/foodrecalls/recalls/Pages/Elecare,-Similac-and-Alimentum-infant-formula-products.aspx

 

This news item was issued on 21 February 2022 by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body for clinical immunology and allergy in Australia and New Zealand.  

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.